CRYM (Cryomass Technologies) 3-Year EPS without NRI Growth Rate : 20.20% (As of Sep. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Cryomass Technologies 3-Year EPS without NRI Growth Rate?

Cryomass Technologies's EPS without NRI for the three months ended in Sep. 2024 was $-0.00.

During the past 3 years, the average EPS without NRI Growth Rate was 20.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was -23.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Cryomass Technologies was 20.20% per year. The lowest was -310.20% per year. And the median was -88.20% per year.

Competitive Comparison of Cryomass Technologies's 3-Year EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Cryomass Technologies's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cryomass Technologies's 3-Year EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cryomass Technologies's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Cryomass Technologies's 3-Year EPS without NRI Growth Rate falls into.

Cryomass Technologies 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

Cryomass Technologies (OTCPK:CRYM) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.

Cryomass Technologies 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Cryomass Technologies's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Cryomass Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cryomass Technologies Inc (OTCPK:CRYM) » Definitions » 3-Year EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

1001 Bannock Street, Suite 612, Denver, CO, USA, 80204

Website

https://www.cryomass.com

Cryomass Technologies Inc designs, manufactures, and licenses field-mobile equipment for the handling of harvested cannabis, hemp, and other high-value plant material. The company owns patented technology that utilizes liquid nitrogen to fully separate, collect, and protect the high-value compounds from the harvested plant. The company's offerings include refinement systems and monitoring and control systems.

Executives

Christian Noel	director, officer: Chief Executive Officer	3531 SOUTH LOGAN ST. SUITE D-357, ENGLEWOOD CO 80113
Philip Blair Mullin	officer: Chief Financial Officer	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Patricia Izabel Kovacevic	officer: GC, Corp Secy, and Head of EA	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Delon Hannes Human	director	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Mark Radke	director	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Mario Gobbo	director	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113